SCHEMBL9060243

SCHEMBL9060243

CCCC/C(=N/c1ccccc1N1CCOCC1)N(C)C.CN/C(=N\c1ccccc1N1CCOCC1)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 3/20 0.38
NPSR1 Q6W5P4 1/20 0.36
ALDH1A1 P00352 6/20 0.35
RECQL P46063 1/20 0.35
NAPEPLD Q6IQ20 5/20 0.35
MAPT P10636 1/20 0.35
NPY1R P25929 1/20 0.35
NPY2R P49146 1/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 1/20 0.33
KCNQ2 O43526 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
GPR55 Q9Y2T6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9060248 1.00 SMN1; SMN2 (0.41) SMN1; SMN2LMNANPSR1ALDH1A1RECQL
SCHEMBL9424054 0.89 SMN1; SMN2 (0.47) SMN1; SMN2LMNANPSR1ALDH1A1RECQL
SCHEMBL9424052 0.89 SMN1; SMN2 (0.47) SMN1; SMN2LMNANPSR1ALDH1A1RECQL
SCHEMBL9424709 0.84 ALDH1A1 (0.39) SMN1; SMN2LMNANPSR1ALDH1A1MAPT
SCHEMBL9424714 0.84 ALDH1A1 (0.39) SMN1; SMN2LMNANPSR1ALDH1A1MAPT
SCHEMBL9424057 0.82 LMNA (0.44) SMN1; SMN2LMNANPSR1ALDH1A1RECQL
SCHEMBL9424059 0.82 LMNA (0.44) SMN1; SMN2LMNANPSR1ALDH1A1RECQL
SCHEMBL9059309 0.78 SMN1; SMN2 (0.45) SMN1; SMN2LMNANPSR1ALDH1A1RECQL
SCHEMBL9059307 0.78 SMN1; SMN2 (0.45) SMN1; SMN2LMNANPSR1ALDH1A1RECQL
SCHEMBL9059067 0.78 SMN1; SMN2 (0.50) SMN1; SMN2LMNANPSR1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed